Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AZD1656 as Add-on to Metformin in Type 2 Diabetes
NCT01020123Phase 2Completed
- Sponsor
- AstraZeneca
- Start
- Oct 2009
- Primary completion
- Feb 2011
- Modality
- Small Molecules
- Countries
- 11
01
Overview
A Phase 2 trial of AZD1656 in type 2 diabetes mellitus (T2DM), sponsored by AstraZeneca. Started Oct 2009; status: completed.
02
Drugs
AZD1656
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01020123.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01020123.